| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of chromatin | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC19P H2BC12 | 2.99e-18 | 100 | 103 | 15 | GO:0030527 |
| GeneOntologyMolecularFunction | protein heterodimerization activity | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 PIK3R1 H2BC5 H2BC3 H2BC19P H2BC12 | 2.13e-10 | 398 | 103 | 16 | GO:0046982 |
| GeneOntologyMolecularFunction | structural molecule activity | SHANK1 H2BC11 NEB H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MRPS17 H2BC5 H2BC3 RPL22L1 H2BC19P RPL13A H2BC12 | 2.44e-08 | 891 | 103 | 20 | GO:0005198 |
| GeneOntologyMolecularFunction | STAT family protein binding | 3.67e-05 | 13 | 103 | 3 | GO:0097677 | |
| GeneOntologyMolecularFunction | protein dimerization activity | H2BC11 CD300H H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 PIK3R1 H2BC5 H2BC3 H2BC19P ANO3 H2BC12 | 4.09e-05 | 1205 | 103 | 18 | GO:0046983 |
| GeneOntologyMolecularFunction | calcium:monoatomic cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration | 7.88e-05 | 3 | 103 | 2 | GO:1905060 | |
| GeneOntologyMolecularFunction | thiol oxidase activity | 3.90e-04 | 6 | 103 | 2 | GO:0016972 | |
| GeneOntologyMolecularFunction | GPI-linked ephrin receptor activity | 5.44e-04 | 7 | 103 | 2 | GO:0005004 | |
| GeneOntologyBiologicalProcess | nucleosome organization | H2BC11 ATAD2 H2BC1 SETD2 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC3 SPTY2D1 | 1.67e-13 | 142 | 99 | 13 | GO:0034728 |
| GeneOntologyBiologicalProcess | nucleosome assembly | H2BC11 ATAD2 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC3 SPTY2D1 | 6.33e-13 | 122 | 99 | 12 | GO:0006334 |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | H2BC11 ATAD2 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC3 SPTY2D1 EP300 | 2.08e-10 | 249 | 99 | 13 | GO:0065004 |
| GeneOntologyBiologicalProcess | innate immune response in mucosa | 5.67e-09 | 30 | 99 | 6 | GO:0002227 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | H2BC11 TEX15 EYA1 ATAD2 H2BC1 SETD2 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 NFRKB SMARCA1 H2BC3 SPTY2D1 EP300 | 1.33e-08 | 741 | 99 | 18 | GO:0006338 |
| GeneOntologyBiologicalProcess | mucosal immune response | 1.09e-07 | 48 | 99 | 6 | GO:0002385 | |
| GeneOntologyBiologicalProcess | antibacterial humoral response | 1.72e-07 | 85 | 99 | 7 | GO:0019731 | |
| GeneOntologyBiologicalProcess | organ or tissue specific immune response | 2.25e-07 | 54 | 99 | 6 | GO:0002251 | |
| GeneOntologyBiologicalProcess | chromatin organization | H2BC11 TEX15 EYA1 ATAD2 H2BC1 SETD2 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 NFRKB SMARCA1 H2BC3 SPTY2D1 EP300 | 2.33e-07 | 896 | 99 | 18 | GO:0006325 |
| GeneOntologyBiologicalProcess | defense response to Gram-positive bacterium | 6.35e-07 | 150 | 99 | 8 | GO:0050830 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | H2BC11 TEX15 EYA1 ATAD2 H2BC1 SETD2 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 NFRKB SMARCA1 H2BC3 SPTY2D1 EP300 | 1.13e-06 | 999 | 99 | 18 | GO:0071824 |
| GeneOntologyBiologicalProcess | antimicrobial humoral immune response mediated by antimicrobial peptide | 3.78e-06 | 134 | 99 | 7 | GO:0061844 | |
| GeneOntologyBiologicalProcess | antimicrobial humoral response | 3.21e-05 | 186 | 99 | 7 | GO:0019730 | |
| GeneOntologyBiologicalProcess | humoral immune response | 1.58e-04 | 321 | 99 | 8 | GO:0006959 | |
| GeneOntologyCellularComponent | nucleosome | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC19P H2BC12 | 2.26e-16 | 138 | 103 | 15 | GO:0000786 |
| GeneOntologyCellularComponent | chromatin | H2BC11 MAGED1 CAMTA2 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 LBX1 NFRKB BUD31 SMARCA1 H2BC5 H2BC3 SPDEF ELK3 ELK4 H2BC19P EP300 H2BC12 | 3.78e-08 | 1480 | 103 | 25 | GO:0000785 |
| GeneOntologyCellularComponent | plasma membrane proton-transporting V-type ATPase complex | 2.40e-05 | 2 | 103 | 2 | GO:0033181 | |
| Domain | H2B | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P H2BC12 | 2.82e-30 | 21 | 104 | 15 | SM00427 |
| Domain | HISTONE_H2B | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P H2BC12 | 2.82e-30 | 21 | 104 | 15 | PS00357 |
| Domain | Histone_H2B | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P H2BC12 | 2.82e-30 | 21 | 104 | 15 | IPR000558 |
| Domain | Histone | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P H2BC12 | 7.23e-22 | 56 | 104 | 15 | PF00125 |
| Domain | Histone_H2A/H2B/H3 | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P H2BC12 | 7.23e-22 | 56 | 104 | 15 | IPR007125 |
| Domain | Histone-fold | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P H2BC12 | 4.79e-19 | 83 | 104 | 15 | IPR009072 |
| Domain | - | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.13e-15 | 69 | 104 | 12 | 1.10.20.10 |
| Domain | DM15 | 3.07e-05 | 2 | 104 | 2 | SM00684 | |
| Domain | ATPase_V0-cplx_csu/dsu | 3.07e-05 | 2 | 104 | 2 | IPR002843 | |
| Domain | CG-1 | 3.07e-05 | 2 | 104 | 2 | PF03859 | |
| Domain | Ero1 | 3.07e-05 | 2 | 104 | 2 | IPR007266 | |
| Domain | vATP-synt_AC39 | 3.07e-05 | 2 | 104 | 2 | PF01992 | |
| Domain | CG-1 | 3.07e-05 | 2 | 104 | 2 | SM01076 | |
| Domain | CG-1_dom | 3.07e-05 | 2 | 104 | 2 | IPR005559 | |
| Domain | CG_1 | 3.07e-05 | 2 | 104 | 2 | PS51437 | |
| Domain | DM15 | 3.07e-05 | 2 | 104 | 2 | IPR006607 | |
| Domain | ERO1 | 3.07e-05 | 2 | 104 | 2 | PF04137 | |
| Domain | ATPase_V0-cplx_dsu | 3.07e-05 | 2 | 104 | 2 | IPR016727 | |
| Domain | IQ | 4.73e-05 | 71 | 104 | 5 | PF00612 | |
| Domain | IQ | 8.90e-05 | 81 | 104 | 5 | SM00015 | |
| Domain | Na_Ca_Ex | 9.18e-05 | 3 | 104 | 2 | IPR004836 | |
| Domain | Na_Ca_Ex_C-exten | 9.18e-05 | 3 | 104 | 2 | IPR032452 | |
| Domain | Na_Ca_ex_C | 9.18e-05 | 3 | 104 | 2 | PF16494 | |
| Domain | IQ_motif_EF-hand-BS | 1.47e-04 | 90 | 104 | 5 | IPR000048 | |
| Domain | IQ | 1.71e-04 | 93 | 104 | 5 | PS50096 | |
| Domain | ETS_DOMAIN_1 | 4.97e-04 | 28 | 104 | 3 | PS00345 | |
| Domain | ETS_DOMAIN_2 | 4.97e-04 | 28 | 104 | 3 | PS00346 | |
| Domain | ETS | 4.97e-04 | 28 | 104 | 3 | SM00413 | |
| Domain | Ets_dom | 4.97e-04 | 28 | 104 | 3 | IPR000418 | |
| Domain | ETS_DOMAIN_3 | 4.97e-04 | 28 | 104 | 3 | PS50061 | |
| Domain | Ets | 4.97e-04 | 28 | 104 | 3 | PF00178 | |
| Domain | CAMSAP_CH | 6.33e-04 | 7 | 104 | 2 | PF11971 | |
| Domain | La | 6.33e-04 | 7 | 104 | 2 | PF05383 | |
| Domain | LA | 6.33e-04 | 7 | 104 | 2 | SM00715 | |
| Domain | CAMSAP_CH | 6.33e-04 | 7 | 104 | 2 | IPR022613 | |
| Domain | Lupus_La_RNA-bd | 6.33e-04 | 7 | 104 | 2 | IPR006630 | |
| Domain | HTH_LA | 6.33e-04 | 7 | 104 | 2 | PS50961 | |
| Domain | Calx_beta | 8.41e-04 | 8 | 104 | 2 | SM00237 | |
| Domain | Calx_beta | 1.08e-03 | 9 | 104 | 2 | IPR003644 | |
| Domain | NaCa_Exmemb | 1.08e-03 | 9 | 104 | 2 | IPR004837 | |
| Domain | Na_Ca_ex | 1.08e-03 | 9 | 104 | 2 | PF01699 | |
| Domain | Calx-beta | 1.08e-03 | 9 | 104 | 2 | PF03160 | |
| Domain | JAB_MPN | 1.95e-03 | 12 | 104 | 2 | SM00232 | |
| Domain | JAMM/MPN+_dom | 1.95e-03 | 12 | 104 | 2 | IPR000555 | |
| Domain | JAB | 1.95e-03 | 12 | 104 | 2 | PF01398 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 2.68e-03 | 14 | 104 | 2 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 2.68e-03 | 14 | 104 | 2 | PS00790 | |
| Domain | Eph_TM | 2.68e-03 | 14 | 104 | 2 | IPR027936 | |
| Domain | Tyr_kinase_rcpt_V_CS | 2.68e-03 | 14 | 104 | 2 | IPR001426 | |
| Domain | EPH_lbd | 2.68e-03 | 14 | 104 | 2 | SM00615 | |
| Domain | Ephrin_lbd | 2.68e-03 | 14 | 104 | 2 | PF01404 | |
| Domain | EphA2_TM | 2.68e-03 | 14 | 104 | 2 | PF14575 | |
| Domain | Tyr_kinase_ephrin_rcpt | 2.68e-03 | 14 | 104 | 2 | IPR016257 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 2.68e-03 | 14 | 104 | 2 | IPR001090 | |
| Domain | EPH_LBD | 2.68e-03 | 14 | 104 | 2 | PS51550 | |
| Domain | - | 2.92e-03 | 106 | 104 | 4 | 1.10.150.50 | |
| Domain | SAM/pointed | 4.16e-03 | 117 | 104 | 4 | IPR013761 | |
| Domain | PG_binding_1 | 5.47e-03 | 20 | 104 | 2 | PF01471 | |
| Domain | Peptidoglycan-bd-like | 5.47e-03 | 20 | 104 | 2 | IPR002477 | |
| Pathway | REACTOME_REPLACEMENT_OF_PROTAMINES_BY_NUCLEOSOMES_IN_THE_MALE_PRONUCLEUS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.51e-20 | 42 | 83 | 13 | M48029 |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | H2BC11 EYA1 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 PPP5C H2BC5 H2BC3 H2BC12 | 3.05e-19 | 78 | 83 | 15 | M27589 |
| Pathway | REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.56e-18 | 55 | 83 | 13 | M29526 |
| Pathway | REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.53e-17 | 62 | 83 | 13 | M27700 |
| Pathway | REACTOME_DNA_METHYLATION | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.96e-17 | 64 | 83 | 13 | M27429 |
| Pathway | REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3 | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.10e-17 | 66 | 83 | 13 | M27488 |
| Pathway | REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.54e-17 | 67 | 83 | 13 | M27342 |
| Pathway | REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.54e-17 | 67 | 83 | 13 | M39003 |
| Pathway | REACTOME_MEIOTIC_RECOMBINATION | H2BC11 TEX15 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.68e-17 | 88 | 83 | 14 | M1011 |
| Pathway | REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.28e-17 | 68 | 83 | 13 | M27587 |
| Pathway | REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.28e-17 | 68 | 83 | 13 | M27658 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 EP300 H2BC12 | 1.03e-16 | 89 | 83 | 14 | M27943 |
| Pathway | REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 EP300 H2BC12 | 1.21e-16 | 90 | 83 | 14 | M29668 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_THE_HUMAN_SILENCING_HUB_HUSH_COMPLEX | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.39e-16 | 70 | 83 | 13 | M48261 |
| Pathway | REACTOME_CHROMATIN_MODIFICATIONS_DURING_THE_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.39e-16 | 70 | 83 | 13 | M48028 |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 EP300 H2BC12 | 1.42e-16 | 91 | 83 | 14 | M27101 |
| Pathway | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.06e-16 | 72 | 83 | 13 | M29714 |
| Pathway | REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.06e-16 | 72 | 83 | 13 | M27132 |
| Pathway | REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.49e-16 | 73 | 83 | 13 | M27166 |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 EP300 H2BC12 | 3.11e-16 | 96 | 83 | 14 | M27792 |
| Pathway | REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.62e-16 | 75 | 83 | 13 | M27343 |
| Pathway | REACTOME_MEIOTIC_SYNAPSIS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.22e-16 | 78 | 83 | 13 | M1061 |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.42e-16 | 79 | 83 | 13 | M27191 |
| Pathway | REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 EP300 H2BC12 | 1.15e-15 | 105 | 83 | 14 | M27425 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_KRAB_ZFP_PROTEINS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 ZNF257 H2BC5 H2BC3 H2BC12 | 1.50e-15 | 107 | 83 | 14 | M48260 |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | H2BC11 ELP1 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 EP300 H2BC12 | 3.57e-15 | 142 | 83 | 15 | M27233 |
| Pathway | REACTOME_BASE_EXCISION_REPAIR | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.39e-15 | 90 | 83 | 13 | M2158 |
| Pathway | REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.39e-15 | 90 | 83 | 13 | M27691 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.83e-15 | 93 | 83 | 13 | M27487 |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 EP300 H2BC12 | 6.92e-15 | 119 | 83 | 14 | M607 |
| Pathway | REACTOME_MEIOSIS | H2BC11 TEX15 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.80e-15 | 120 | 83 | 14 | M529 |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.89e-15 | 94 | 83 | 13 | M1080 |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.89e-15 | 94 | 83 | 13 | M27230 |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 PPP5C PIK3R1 H2BC5 H2BC3 MMP7 EP300 H2BC12 | 8.52e-15 | 220 | 83 | 17 | M27794 |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 EP300 H2BC12 | 9.87e-15 | 122 | 83 | 14 | M29689 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.20e-14 | 97 | 83 | 13 | M48262 |
| Pathway | REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.20e-14 | 97 | 83 | 13 | M27590 |
| Pathway | REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 EP300 H2BC12 | 1.95e-14 | 128 | 83 | 14 | M48019 |
| Pathway | REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.06e-14 | 104 | 83 | 13 | M29829 |
| Pathway | REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS | H2BC11 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC5 H2BC3 H2BC12 | 3.31e-14 | 59 | 83 | 11 | M27763 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.94e-14 | 106 | 83 | 13 | M27458 |
| Pathway | REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.06e-14 | 108 | 83 | 13 | M27426 |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | H2BC11 EYA1 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 PPP5C H2BC5 H2BC3 H2BC12 | 5.31e-14 | 170 | 83 | 15 | M27582 |
| Pathway | REACTOME_AMYLOID_FIBER_FORMATION | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.45e-14 | 110 | 83 | 13 | M27958 |
| Pathway | REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.45e-14 | 110 | 83 | 13 | M27696 |
| Pathway | REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.27e-14 | 111 | 83 | 13 | M27187 |
| Pathway | REACTOME_TELOMERE_MAINTENANCE | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.19e-14 | 112 | 83 | 13 | M4052 |
| Pathway | WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.19e-14 | 112 | 83 | 13 | M48334 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 ZNF257 H2BC5 H2BC3 H2BC12 | 8.44e-14 | 142 | 83 | 14 | M48257 |
| Pathway | REACTOME_HCMV_LATE_EVENTS | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.30e-13 | 116 | 83 | 13 | M29806 |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 EP300 H2BC12 | 1.66e-13 | 149 | 83 | 14 | M27888 |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.48e-13 | 125 | 83 | 13 | M27186 |
| Pathway | REACTOME_REPRODUCTION | H2BC11 TEX15 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.75e-13 | 158 | 83 | 14 | M26956 |
| Pathway | REACTOME_DNA_REPLICATION_PRE_INITIATION | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 DBF4 H2BC5 H2BC3 H2BC12 | 4.09e-13 | 159 | 83 | 14 | M27665 |
| Pathway | REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.24e-13 | 129 | 83 | 13 | M27795 |
| Pathway | REACTOME_G2_M_CHECKPOINTS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 DBF4 H2BC5 H2BC3 H2BC12 | 8.06e-13 | 167 | 83 | 14 | M19381 |
| Pathway | REACTOME_PROTEIN_UBIQUITINATION | H2BC11 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC5 H2BC3 H2BC12 | 9.72e-13 | 79 | 83 | 11 | M27742 |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 PPP5C PIK3R1 H2BC5 H2BC3 MMP7 EP300 H2BC12 | 1.11e-12 | 296 | 83 | 17 | M27869 |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.26e-12 | 138 | 83 | 13 | M29805 |
| Pathway | KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.38e-12 | 139 | 83 | 13 | M4741 |
| Pathway | REACTOME_CHROMOSOME_MAINTENANCE | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.38e-12 | 139 | 83 | 13 | M868 |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.38e-12 | 139 | 83 | 13 | M715 |
| Pathway | REACTOME_HOMOLOGY_DIRECTED_REPAIR | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.52e-12 | 140 | 83 | 13 | M27584 |
| Pathway | REACTOME_MITOTIC_PROPHASE | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.82e-12 | 142 | 83 | 13 | M27660 |
| Pathway | REACTOME_DNA_REPLICATION | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 DBF4 H2BC5 H2BC3 H2BC12 | 3.81e-12 | 187 | 83 | 14 | M1017 |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | H2BC11 ELP1 H2BC18 H2BC1 SETD2 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 EP300 H2BC12 | 3.86e-12 | 272 | 83 | 16 | M29619 |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 5.03e-12 | 46 | 83 | 9 | MM14935 | |
| Pathway | REACTOME_HCMV_INFECTION | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.91e-12 | 162 | 83 | 13 | M29804 |
| Pathway | REACTOME_DEUBIQUITINATION | H2BC11 H2BC18 STAMBP H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 NFRKB H2BC5 H2BC3 EP300 H2BC12 | 1.62e-11 | 299 | 83 | 16 | M27574 |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 ZNF257 H2BC5 H2BC3 EP300 H2BC12 | 1.85e-11 | 254 | 83 | 15 | M27131 |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | 2.78e-11 | 55 | 83 | 9 | MM14932 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | 3.90e-11 | 57 | 83 | 9 | MM15298 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 EP300 H2BC12 | 7.40e-11 | 233 | 83 | 14 | M27099 |
| Pathway | REACTOME_DNA_REPAIR | H2BC11 EYA1 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 PPP5C NFRKB H2BC5 H2BC3 H2BC12 | 7.74e-11 | 332 | 83 | 16 | M15434 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 EP300 H2BC12 | 9.28e-11 | 237 | 83 | 14 | M27786 |
| Pathway | REACTOME_CELLULAR_SENESCENCE | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.17e-10 | 197 | 83 | 13 | M27188 |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 EP300 H2BC12 | 1.52e-10 | 246 | 83 | 14 | M10189 |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 1.53e-10 | 44 | 83 | 8 | MM15527 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 PPP5C PIK3R1 H2BC5 H2BC3 MMP7 EP300 | 3.15e-10 | 133 | 83 | 11 | MM15529 |
| Pathway | REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE | 4.45e-10 | 31 | 83 | 7 | MM17225 | |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.88e-10 | 221 | 83 | 13 | M27578 |
| Pathway | REACTOME_SIGNALING_BY_WNT | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 PRKG1 EP300 H2BC12 | 7.30e-10 | 330 | 83 | 15 | M7847 |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 DBF4 H2BC5 H2BC3 H2BC12 | 1.38e-09 | 291 | 83 | 14 | M16647 |
| Pathway | REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES | 1.69e-09 | 37 | 83 | 7 | MM14883 | |
| Pathway | REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION | 2.06e-09 | 38 | 83 | 7 | MM15434 | |
| Pathway | REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA | 2.50e-09 | 39 | 83 | 7 | MM14850 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 3.05e-09 | 63 | 83 | 8 | MM15613 | |
| Pathway | REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS | 7.18e-09 | 45 | 83 | 7 | MM15508 | |
| Pathway | REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ | 9.86e-09 | 47 | 83 | 7 | MM15296 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 PPP5C PIK3R1 H2BC5 H2BC3 MMP7 EP300 | 1.46e-08 | 191 | 83 | 11 | MM15586 |
| Pathway | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | 1.54e-08 | 50 | 83 | 7 | MM15308 | |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | 2.69e-08 | 54 | 83 | 7 | MM14904 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 3.48e-08 | 56 | 83 | 7 | MM17236 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.72e-08 | 323 | 83 | 13 | M27080 |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | H2BC11 H2BC18 H2BC1 SETD2 H2BC13 H2BC15 H2BC14 H2BC9 H2BC5 H2BC3 | 7.48e-08 | 175 | 83 | 10 | MM14941 |
| Pathway | REACTOME_PROTEIN_UBIQUITINATION | 1.00e-07 | 65 | 83 | 7 | MM15490 | |
| Pathway | REACTOME_BASE_EXCISION_REPAIR | 1.24e-07 | 67 | 83 | 7 | MM15429 | |
| Pathway | REACTOME_M_PHASE | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 ALMS1 H2BC5 H2BC3 H2BC12 | 1.30e-07 | 417 | 83 | 14 | M27662 |
| Pathway | REACTOME_CELL_CYCLE_MITOTIC | H2BC11 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 ALMS1 DBF4 H2BC5 H2BC3 EP300 H2BC12 | 1.39e-07 | 561 | 83 | 16 | M5336 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | H2BC11 MYO6 FAM91A1 H2BC12L DOCK5 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 PIK3R1 H2BC5 H2BC3 VAV1 H2BC12 | 1.48e-07 | 720 | 83 | 18 | M41838 |
| Pubmed | Inhibition of core histones acetylation by carcinogenic nickel(II). | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P H2BC12 | 5.23e-36 | 18 | 106 | 15 | 16283522 |
| Pubmed | Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. | H2BC11 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P H2BC12 | 7.39e-33 | 18 | 106 | 14 | 12757711 |
| Pubmed | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.44e-28 | 22 | 106 | 13 | 16713563 | |
| Pubmed | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.02e-27 | 23 | 106 | 13 | 16307923 | |
| Pubmed | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P H2BC12 | 1.96e-23 | 77 | 106 | 15 | 12408966 | |
| Pubmed | H2BC11 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.79e-23 | 30 | 106 | 12 | 16319397 | |
| Pubmed | Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA. | H2BC11 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 EP300 H2BC12 | 3.07e-20 | 69 | 106 | 13 | 11689053 |
| Pubmed | Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P EP300 H2BC12 SLC27A2 | 6.64e-20 | 203 | 106 | 17 | 16916647 |
| Pubmed | Histone H2B as a functionally important plasminogen receptor on macrophages. | 7.90e-20 | 15 | 106 | 9 | 17690254 | |
| Pubmed | Quantitative proteomic analysis of post-translational modifications of human histones. | H2BC11 H2BC12L H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC12 | 3.82e-19 | 17 | 106 | 9 | 16627869 |
| Pubmed | H2BC11 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 EP300 H2BC12 | 6.62e-19 | 86 | 106 | 13 | 11080476 | |
| Pubmed | 9.31e-19 | 11 | 106 | 8 | 15197225 | ||
| Pubmed | Histone modifications associated with somatic hypermutation. | 9.31e-19 | 11 | 106 | 8 | 16039583 | |
| Pubmed | H2BC11 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.32e-18 | 73 | 106 | 12 | 14657027 | |
| Pubmed | H2BC11 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.32e-18 | 73 | 106 | 12 | 9566873 | |
| Pubmed | H2BC11 LARP1B LANCL2 CCIN H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 RPL13A H2BC12 | 1.57e-15 | 438 | 106 | 18 | 21630459 | |
| Pubmed | H2BC11 ELP1 PRPF8 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC5 H2BC3 RPL13A H2BC12 | 4.09e-15 | 212 | 106 | 14 | 23463506 | |
| Pubmed | H2BC11 PFKFB2 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.63e-15 | 277 | 106 | 15 | 30745168 | |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 9.61e-15 | 67 | 106 | 10 | 25253489 | |
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | H2BC11 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 RPL13A H2BC12 | 5.55e-14 | 256 | 106 | 14 | 35777956 |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | H2BC11 MYO1D MYO6 LARP1 PRPF8 H2BC18 STAMBP H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 RPL13A H2BC12 | 5.64e-14 | 626 | 106 | 19 | 33644029 |
| Pubmed | 9.08e-14 | 55 | 106 | 9 | 9439656 | ||
| Pubmed | H2BC11 NEB PRPF8 LANCL2 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P RPL22L1 H2BC19P RPL13A H2BC12 | 1.09e-13 | 844 | 106 | 21 | 25963833 | |
| Pubmed | H2BC11 NOL9 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 ZNF257 SMARCA1 H2BC5 H2BC3 H2BC12 KLB | 6.23e-13 | 451 | 106 | 16 | 36168627 | |
| Pubmed | Gene-specific characterization of human histone H2B by electron capture dissociation. | 1.43e-12 | 6 | 106 | 5 | 16457587 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | H2BC11 MAGED1 MYO6 LARP1 PRPF8 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.45e-12 | 477 | 106 | 16 | 31300519 |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 SMARCA1 H2BC5 H2BC3 H2BC12 | 2.44e-12 | 271 | 106 | 13 | 32433965 |
| Pubmed | H2BC11 PRPF8 H2BC18 ESF1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 RPL13A H2BC12 | 3.73e-12 | 425 | 106 | 15 | 21081503 | |
| Pubmed | Regulation of error-prone translesion synthesis by Spartan/C1orf124. | 1.11e-11 | 59 | 106 | 8 | 23254330 | |
| Pubmed | H2BC11 MYO1D LARP1 MMP21 NEB PRPF8 H2BC18 ESF1 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 ASPM SMARCA1 H2BC5 H2BC3 SPDEF RPL13A H2BC12 EPHA4 | 5.59e-11 | 1442 | 106 | 23 | 35575683 | |
| Pubmed | H2BC11 GNL3L LARP1 LARP1B PRPF8 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MRPS17 MEPCE H2BC5 H2BC3 RPL13A H2BC12 | 2.85e-10 | 1153 | 106 | 20 | 29845934 | |
| Pubmed | Endotoxin-neutralizing antimicrobial proteins of the human placenta. | 4.07e-10 | 5 | 106 | 4 | 11859126 | |
| Pubmed | Biochemical and antibacterial analysis of human wound and blister fluid. | 4.07e-10 | 5 | 106 | 4 | 8620898 | |
| Pubmed | 4.68e-10 | 14 | 106 | 5 | 10064132 | ||
| Pubmed | PRPF8 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC21 H2BC5 H2BC3 | 8.30e-10 | 206 | 106 | 10 | 22174317 | |
| Pubmed | H2BC11 PRPF8 LANCL2 H2BC18 STAMBP H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 MEPCE H2BC5 H2BC3 H2BC12 | 1.41e-09 | 878 | 106 | 17 | 37223481 | |
| Pubmed | Antimicrobial peptides in the first line defence of human colon mucosa. | 1.98e-09 | 18 | 106 | 5 | 12860195 | |
| Pubmed | 2.83e-09 | 7 | 106 | 4 | 15019208 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | LARP1 PRPF8 H2BC18 ESF1 H2BC12L H2BC1 SETD2 H2BC13 H2BC15 H2BC14 H2BC9 UTP11 NFRKB BUD31 SUGP1 H2BC5 H2BC12 | 4.85e-09 | 954 | 106 | 17 | 36373674 |
| Pubmed | 1.04e-08 | 88 | 106 | 7 | 26318153 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | GNL3L MAGED1 MYO6 ELP1 LARP1 NOL9 PRPF8 GTF3C3 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC5 RPL22L1 RPL13A H2BC12 | 4.67e-08 | 1257 | 106 | 18 | 37317656 |
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 8858344 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | GNL3L MYO1D MYO6 ERO1A ELP1 LARP1 NOL9 PRPF8 ATAD2 LANCL2 GTF3C3 ESF1 H2BC15 ATP6V0D1 PPP5C SMARCA1 H2BC5 H2BC20P RPL13A | 5.79e-08 | 1425 | 106 | 19 | 30948266 |
| Pubmed | 4.50e-07 | 152 | 106 | 7 | 38360978 | ||
| Pubmed | H2BC11 MYO6 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC5 SPDEF H2BC12 EPHA7 | 4.60e-07 | 622 | 106 | 12 | 14574404 | |
| Pubmed | Autoimmunity to isomerized histone H2B in systemic lupus erythematosus. | 5.47e-07 | 6 | 106 | 3 | 22967069 | |
| Pubmed | MAGED1 MYO1D MYO6 ELP1 LARP1 FAM91A1 PRPF8 LANCL2 GTF3C3 H2BC1 DENND6A H2BC4 PPP5C MRPS17 SMARCA1 H2BC3 RPL13A | 5.96e-07 | 1335 | 106 | 17 | 29229926 | |
| Pubmed | BZW2 ESF1 H2BC13 H2BC15 H2BC17 H2BC21 UTP11 H2BC5 RPL13A H2BC12 | 6.59e-07 | 419 | 106 | 10 | 15635413 | |
| Pubmed | Characterization of the 55-kb mouse histone gene cluster on chromosome 3. | 9.55e-07 | 7 | 106 | 3 | 8858345 | |
| Pubmed | The activity-dependent histone variant H2BE modulates the life span of olfactory neurons. | 9.55e-07 | 7 | 106 | 3 | 23240083 | |
| Pubmed | 9.57e-07 | 247 | 106 | 8 | 30713523 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | H2BC11 GNL3L MYO1D MYO6 LARP1 NOL9 PRPF8 LANCL2 GTF3C3 ESF1 UTP11 MEPCE SMARCA1 RPL22L1 RPL13A H2BC12 | 1.34e-06 | 1257 | 106 | 16 | 36526897 |
| Pubmed | 1.52e-06 | 8 | 106 | 3 | 9710638 | ||
| Pubmed | 1.71e-06 | 267 | 106 | 8 | 33417871 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | H2BC11 GNL3L MYO6 PRPF8 H2BC13 H2BC15 H2BC14 H2BC4 H2BC17 H2BC5 H2BC3 RPL13A H2BC12 | 1.92e-06 | 847 | 106 | 13 | 35235311 |
| Pubmed | 2.28e-06 | 9 | 106 | 3 | 26479788 | ||
| Pubmed | H2BC11 MYO6 NOL9 PRPF8 GTF3C3 ESF1 UTP11 RPL13A SPTY2D1 H2BC12 | 2.36e-06 | 483 | 106 | 10 | 36912080 | |
| Pubmed | LARP1 PRPF8 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC5 RPL13A | 2.73e-06 | 491 | 106 | 10 | 22623428 | |
| Pubmed | Human histone gene organization: nonregular arrangement within a large cluster. | 3.97e-06 | 35 | 106 | 4 | 9119399 | |
| Pubmed | GNL3L MMP21 ELL3 SETD2 ALMS1 LBX1 PIK3R1 NFRKB ASPM MEPCE SMARCA1 H2BC3 EP300 VAV1 | 7.68e-06 | 1116 | 106 | 14 | 31753913 | |
| Pubmed | MAGED1 BZW2 LARP1 LARP1B PRPF8 GTF3C3 MRPS17 UTP11 ASPM H2BC3 RPL22L1 RPL13A H2BC12 | 8.38e-06 | 971 | 106 | 13 | 33306668 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NOL9 PRPF8 DOCK5 SETD2 H2BC15 H2BC14 H2BC9 NFRKB BUD31 H2BC5 RPL13A SPTY2D1 EP300 H2BC12 SLC27A2 | 9.08e-06 | 1294 | 106 | 15 | 30804502 |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 24631925 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 10818100 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 26787195 | ||
| Pubmed | Oxidative protein folding by an endoplasmic reticulum-localized peroxiredoxin. | 9.20e-06 | 2 | 106 | 2 | 21145486 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 8611618 | ||
| Pubmed | Roles of Na(+)/Ca(2+) exchanger isoforms NCX1 and NCX2 in motility in mouse ileum. | 9.20e-06 | 2 | 106 | 2 | 27411318 | |
| Pubmed | Na+/Ca2+ exchanger contributes to stool transport in mice with experimental diarrhea. | 9.20e-06 | 2 | 106 | 2 | 27928109 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 26587807 | ||
| Pubmed | Ataxia and Purkinje cell degeneration in mice lacking the CAMTA1 transcription factor. | 9.20e-06 | 2 | 106 | 2 | 25049392 | |
| Pubmed | A novel family of calmodulin-binding transcription activators in multicellular organisms. | 9.20e-06 | 2 | 106 | 2 | 11925432 | |
| Pubmed | Glutathione limits Ero1-dependent oxidation in the endoplasmic reticulum. | 9.20e-06 | 2 | 106 | 2 | 15161913 | |
| Pubmed | The cellular oxygen tension regulates expression of the endoplasmic oxidoreductase ERO1-Lalpha. | 9.20e-06 | 2 | 106 | 2 | 12752442 | |
| Pubmed | Genetic knockout and pharmacologic inhibition of NCX2 cause natriuresis and hypercalciuria. | 9.20e-06 | 2 | 106 | 2 | 25498502 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 7851904 | ||
| Pubmed | 1.21e-05 | 250 | 106 | 7 | 33536335 | ||
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | 1.32e-05 | 353 | 106 | 8 | 27545878 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 1.46e-05 | 358 | 106 | 8 | 32460013 | |
| Pubmed | 1.79e-05 | 177 | 106 | 6 | 26206133 | ||
| Pubmed | 1.87e-05 | 486 | 106 | 9 | 20936779 | ||
| Pubmed | 2.57e-05 | 19 | 106 | 3 | 16522924 | ||
| Pubmed | 2.64e-05 | 638 | 106 | 10 | 31182584 | ||
| Pubmed | ERO1A SLFN12 FAM91A1 CAMTA2 NOL9 LANCL2 MADD ESF1 AP4S1 PIK3R1 NFRKB CAMTA1 SPTY2D1 | 2.66e-05 | 1084 | 106 | 13 | 11544199 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 25203538 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 29594857 | ||
| Pubmed | Net, a new ets transcription factor that is activated by Ras. | 2.76e-05 | 3 | 106 | 2 | 7958835 | |
| Pubmed | Parcellation of the thalamus into distinct nuclei reflects EphA expression and function. | 2.76e-05 | 3 | 106 | 2 | 24036135 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 3562244 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 21382638 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 23063436 | ||
| Pubmed | Lifetime imaging of a fluorescent protein sensor reveals surprising stability of ER thiol redox. | 2.76e-05 | 3 | 106 | 2 | 23589496 | |
| Pubmed | Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway. | 2.76e-05 | 3 | 106 | 2 | 9644975 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 9582374 | ||
| Pubmed | Manipulation of oxidative protein folding and PDI redox state in mammalian cells. | 2.76e-05 | 3 | 106 | 2 | 11707400 | |
| Pubmed | Aberrant Amygdala-Dependent Cued Fear Memory in Na+/Ca2+ Exchanger 1 Heterozygous Mice. | 2.76e-05 | 3 | 106 | 2 | 30324228 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 20554967 | ||
| Pubmed | The downregulation of NCXs is positively correlated with the prognosis of stage II-IV colon cancer. | 2.76e-05 | 3 | 106 | 2 | 34127021 | |
| Pubmed | Sodium-calcium exchange in intracellular calcium handling of human airway smooth muscle. | 2.76e-05 | 3 | 106 | 2 | 21858195 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 21057544 | ||
| Interaction | TNN interactions | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.70e-22 | 23 | 105 | 12 | int:TNN |
| Interaction | CDK5R2 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.75e-20 | 23 | 105 | 11 | int:CDK5R2 |
| Interaction | CYLC1 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.68e-18 | 20 | 105 | 10 | int:CYLC1 |
| Interaction | HMGN3 interactions | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.02e-17 | 64 | 105 | 13 | int:HMGN3 |
| Interaction | H2AC25 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 MEPCE H2BC5 H2BC3 ELK4 EP300 H2BC12 | 1.04e-17 | 84 | 105 | 14 | int:H2AC25 |
| Interaction | LOC102724334 interactions | H2BC11 PRPF8 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MEPCE H2BC5 H2BC3 ELK4 H2BC12 | 1.11e-17 | 134 | 105 | 16 | int:LOC102724334 |
| Interaction | H2BC15 interactions | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MEPCE H2BC5 H2BC3 ELK4 RPL13A H2BC12 | 3.59e-17 | 144 | 105 | 16 | int:H2BC15 |
| Interaction | H2BC18 interactions | H2BC11 GNL3L PRPF8 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MEPCE H2BC5 H2BC3 ELK4 H2BC12 | 5.64e-17 | 180 | 105 | 17 | int:H2BC18 |
| Interaction | DUOX2 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.62e-16 | 30 | 105 | 10 | int:DUOX2 |
| Interaction | H2AC7 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MEPCE H2BC5 H2BC3 ELK4 H2BC12 | 3.62e-16 | 107 | 105 | 14 | int:H2AC7 |
| Interaction | H2AC6 interactions | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC4 H2BC17 H2BC21 MEPCE H2BC5 H2BC3 ELK4 H2BC12 | 4.74e-15 | 100 | 105 | 13 | int:H2AC6 |
| Interaction | H2BC14 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 MEPCE H2BC5 H2BC3 ELK4 H2BC12 | 4.74e-15 | 100 | 105 | 13 | int:H2BC14 |
| Interaction | TEX35 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.78e-15 | 57 | 105 | 11 | int:TEX35 |
| Interaction | H2BC13 interactions | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MEPCE H2BC5 H2BC3 ELK4 RPL13A H2BC12 | 1.50e-14 | 210 | 105 | 16 | int:H2BC13 |
| Interaction | H2BC17 interactions | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MEPCE H2BC5 H2BC3 H2BC12 | 1.68e-14 | 140 | 105 | 14 | int:H2BC17 |
| Interaction | ZNF474 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 ATP6V0D2 H2BC12 | 2.04e-14 | 44 | 105 | 10 | int:ZNF474 |
| Interaction | H2AC14 interactions | H2BC11 PRPF8 H2BC18 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 MEPCE H2BC5 H2BC3 H2BC20P ELK4 H2BC12 | 2.50e-14 | 144 | 105 | 14 | int:H2AC14 |
| Interaction | H2AJ interactions | H2BC11 H2BC18 ESF1 H2BC13 H2BC15 H2BC17 H2BC21 UTP11 MEPCE H2BC5 H2BC3 ELK4 H2BC12 | 1.13e-13 | 127 | 105 | 13 | int:H2AJ |
| Interaction | FAM47B interactions | 1.42e-13 | 13 | 105 | 7 | int:FAM47B | |
| Interaction | H2BC9 interactions | H2BC11 MYO6 TEX15 NEB PRPF8 H2BC18 ESF1 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MEPCE H2BC5 H2BC3 ELK4 H2BC12 | 1.45e-13 | 446 | 105 | 20 | int:H2BC9 |
| Interaction | HMGN4 interactions | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.51e-13 | 100 | 105 | 12 | int:HMGN4 |
| Interaction | H2AC11 interactions | H2BC11 BZW2 NEB H2BC18 H2BC1 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 MEPCE H2BC5 H2BC3 RPL13A H2BC12 | 2.01e-13 | 248 | 105 | 16 | int:H2AC11 |
| Interaction | JPH2 interactions | 4.16e-13 | 25 | 105 | 8 | int:JPH2 | |
| Interaction | DPPA2 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.77e-13 | 40 | 105 | 9 | int:DPPA2 |
| Interaction | H2BC1 interactions | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 MEPCE H2BC5 H2BC3 ELK4 H2BC12 | 4.79e-13 | 178 | 105 | 14 | int:H2BC1 |
| Interaction | MCM5 interactions | H2BC11 LARP1 PRPF8 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P EP300 H2BC12 | 5.43e-13 | 420 | 105 | 19 | int:MCM5 |
| Interaction | H3C1 interactions | H2BC11 MYO6 BZW2 LARP1 NEB ATAD2 GTF3C3 H2BC18 H2BC1 SETD2 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 ZNF257 BUD31 MEPCE SMARCA1 H2BC5 H2BC3 ELK4 RPL13A EP300 H2BC12 | 5.88e-13 | 901 | 105 | 26 | int:H3C1 |
| Interaction | H2AC18 interactions | H2BC11 NEB H2BC18 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 MEPCE H2BC5 H2BC3 H2BC12 | 8.29e-13 | 148 | 105 | 13 | int:H2AC18 |
| Interaction | H2BC12 interactions | H2BC11 LARP1 NEB H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MEPCE H2BC5 H2BC3 ELK4 H2BC12 | 8.71e-13 | 322 | 105 | 17 | int:H2BC12 |
| Interaction | H2BC11 interactions | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MEPCE H2BC5 H2BC3 H2BC12 | 8.76e-13 | 186 | 105 | 14 | int:H2BC11 |
| Interaction | H2AC12 interactions | H2BC11 H2BC18 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 MEPCE H2BC5 H2BC3 ELK4 H2BC12 | 1.13e-12 | 118 | 105 | 12 | int:H2AC12 |
| Interaction | H2BC5 interactions | H2BC11 PRPF8 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 ASPM MEPCE H2BC5 H2BC3 ELK4 H2BC12 | 1.36e-12 | 331 | 105 | 17 | int:H2BC5 |
| Interaction | H2AX interactions | H2BC11 ERO1A EYA1 LARP1B NEB H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MEPCE SMARCA1 H2BC5 H2BC3 H2BC20P EP300 H2BC12 | 3.12e-12 | 593 | 105 | 21 | int:H2AX |
| Interaction | H2AC1 interactions | H2BC11 H2BC18 H2BC1 H2BC15 H2BC17 H2BC21 MEPCE H2BC5 H2BC3 H2BC12 | 3.37e-12 | 71 | 105 | 10 | int:H2AC1 |
| Interaction | HCLS1 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.37e-12 | 71 | 105 | 10 | int:HCLS1 |
| Interaction | H2BC4 interactions | H2BC11 LARP1 NEB H2BC18 H2BC1 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 MEPCE H2BC5 H2BC3 H2BC12 | 5.70e-12 | 259 | 105 | 15 | int:H2BC4 |
| Interaction | H2AC13 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC17 H2BC21 H2BC5 H2BC3 ELK4 H2BC12 | 5.95e-12 | 75 | 105 | 10 | int:H2AC13 |
| Interaction | HMGN2 interactions | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 EP300 H2BC12 | 9.73e-12 | 222 | 105 | 14 | int:HMGN2 |
| Interaction | H2BC26 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MEPCE H2BC5 H2BC3 H2BC12 | 1.25e-11 | 183 | 105 | 13 | int:H2BC26 |
| Interaction | IGSF8 interactions | H2BC11 ELP1 PRPF8 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC5 H2BC3 RPL13A H2BC12 | 2.62e-11 | 239 | 105 | 14 | int:IGSF8 |
| Interaction | UBB interactions | H2BC11 MYO1D FIS1 H2BC18 PCTP H2BC1 H2BC13 H2BC15 H2BC14 DENND6A H2BC9 ATP6V0D1 H2BC17 H2BC21 MEPCE H2BC5 H2BC3 H2BC12 | 3.36e-11 | 467 | 105 | 18 | int:UBB |
| Interaction | RPS27A interactions | H2BC11 MYO6 NEB PRPF8 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 PPP5C MEPCE H2BC5 H2BC3 RPL13A H2BC12 | 3.79e-11 | 536 | 105 | 19 | int:RPS27A |
| Interaction | ELK4 interactions | LARP1 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC5 ELK4 H2BC12 | 4.81e-11 | 92 | 105 | 10 | int:ELK4 |
| Interaction | PCLO interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC12 | 9.97e-11 | 70 | 105 | 9 | int:PCLO |
| Interaction | H2AC4 interactions | H2BC11 GTF3C3 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 ALMS1 MEPCE H2BC5 H2BC3 H2BC20P EP300 H2BC12 | 1.24e-10 | 506 | 105 | 18 | int:H2AC4 |
| Interaction | PSMD14 interactions | H2BC11 LARP1 PFKFB2 PRPF8 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MEPCE H2BC5 H2BC3 H2BC12 | 2.39e-10 | 527 | 105 | 18 | int:PSMD14 |
| Interaction | SFMBT2 interactions | 2.57e-10 | 32 | 105 | 7 | int:SFMBT2 | |
| Interaction | H2AC21 interactions | H2BC11 CAMTA2 H2BC18 H2BC1 H2BC15 H2BC9 H2BC17 H2BC21 MEPCE H2BC5 H2BC3 RPL13A EP300 | 2.71e-10 | 234 | 105 | 13 | int:H2AC21 |
| Interaction | H2BC21 interactions | H2BC11 FAM91A1 NEB PRPF8 ATAD2 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MEPCE SMARCA1 H2BC5 H2BC3 EP300 H2BC12 | 4.47e-10 | 696 | 105 | 20 | int:H2BC21 |
| Interaction | ICAM1 interactions | H2BC11 PRPF8 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC5 H2BC3 RPL13A H2BC12 | 6.75e-10 | 252 | 105 | 13 | int:ICAM1 |
| Interaction | H2AZ1 interactions | H2BC11 GTF3C3 H2BC18 H2BC1 H2BC13 H2BC9 H2BC4 H2BC17 H2BC21 MEPCE SMARCA1 H2BC5 H2BC3 H2BC20P H2BC12 | 8.84e-10 | 371 | 105 | 15 | int:H2AZ1 |
| Interaction | UBA52 interactions | SHANK1 H2BC11 NEB H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MEPCE H2BC5 H2BC3 H2BC12 | 9.74e-10 | 437 | 105 | 16 | int:UBA52 |
| Interaction | H2BC3 interactions | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MEPCE H2BC5 H2BC3 EP300 H2BC12 | 3.02e-09 | 406 | 105 | 15 | int:H2BC3 |
| Interaction | IPO9 interactions | LARP1 H2BC18 H2BC1 H2BC13 H2BC14 H2BC9 H2BC17 H2BC21 MEPCE H2BC5 EP300 H2BC12 | 3.76e-09 | 236 | 105 | 12 | int:IPO9 |
| Interaction | ARHGAP24 interactions | H2BC11 NOL9 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 ZNF257 SMARCA1 H2BC5 H2BC3 H2BC12 KLB | 4.46e-09 | 486 | 105 | 16 | int:ARHGAP24 |
| Interaction | RIOK1 interactions | H2BC11 PRPF8 H2BC18 ESF1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 ELK4 RPL13A EP300 H2BC12 | 4.96e-09 | 562 | 105 | 17 | int:RIOK1 |
| Interaction | H2AC20 interactions | H2BC11 H2BC18 H2BC1 H2BC15 H2BC9 H2BC17 H2BC21 MEPCE H2BC5 H2BC3 ELK4 EP300 H2BC12 | 1.21e-08 | 320 | 105 | 13 | int:H2AC20 |
| Interaction | MEPCE interactions | H2BC11 LARP1 LARP1B PRPF8 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MRPS17 MEPCE H2BC5 H2BC3 RPL13A EP300 H2BC12 | 1.61e-08 | 859 | 105 | 20 | int:MEPCE |
| Interaction | MAP1B interactions | H2BC11 PRPF8 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 PPP5C H2BC5 H2BC3 RPL13A H2BC12 | 1.91e-08 | 539 | 105 | 16 | int:MAP1B |
| Interaction | BTF3 interactions | H2BC11 MYO1D MYO6 LARP1 PRPF8 H2BC18 STAMBP H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 RPL13A H2BC12 | 2.78e-08 | 799 | 105 | 19 | int:BTF3 |
| Interaction | PDCD4 interactions | H2BC11 ATAD2 H2BC1 H2BC14 H2BC9 H2BC4 H2BC21 H2BC5 EP300 H2BC12 | 2.82e-08 | 176 | 105 | 10 | int:PDCD4 |
| Interaction | PDS5B interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.14e-08 | 178 | 105 | 10 | int:PDS5B |
| Interaction | GRB2 interactions | HUNK H2BC18 STAMBP EFHC2 DOCK5 AP4S1 H2BC13 H2BC15 H2BC14 H2BC9 PPP5C PIK3R1 H2BC5 RPL22L1 EP300 VAV1 H2BC12 EPHA4 EPHA7 | 3.19e-08 | 806 | 105 | 19 | int:GRB2 |
| Interaction | ADARB1 interactions | H2BC11 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 SMARCA1 H2BC5 H2BC3 RPL13A SPTY2D1 H2BC12 | 3.61e-08 | 489 | 105 | 15 | int:ADARB1 |
| Interaction | HMGA1 interactions | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 SMARCA1 H2BC5 H2BC3 H2BC20P H2BC12 | 3.73e-08 | 419 | 105 | 14 | int:HMGA1 |
| Interaction | TMEM196 interactions | 4.79e-08 | 8 | 105 | 4 | int:TMEM196 | |
| Interaction | USF3 interactions | 5.08e-08 | 20 | 105 | 5 | int:USF3 | |
| Interaction | H3-4 interactions | H2BC11 ATAD2 SETD2 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC21 H2BC5 H2BC20P ELK4 EP300 H2BC12 | 8.54e-08 | 448 | 105 | 14 | int:H3-4 |
| Interaction | TOMM70 interactions | 1.07e-07 | 153 | 105 | 9 | int:TOMM70 | |
| Interaction | H3C15 interactions | H2BC11 MYO6 ESF1 H2BC1 H2BC13 H2BC9 H2BC4 H2BC21 H2BC5 H2BC12 | 1.30e-07 | 207 | 105 | 10 | int:H3C15 |
| Interaction | EIF1AX interactions | 1.35e-07 | 113 | 105 | 8 | int:EIF1AX | |
| Interaction | MCM2 interactions | H2BC11 ELP1 NEB LANCL2 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 DBF4 H2BC5 H2BC3 RPL22L1 RPL13A EP300 H2BC12 | 1.48e-07 | 1081 | 105 | 21 | int:MCM2 |
| Interaction | DOK2 interactions | 1.65e-07 | 116 | 105 | 8 | int:DOK2 | |
| Interaction | H2AZ2 interactions | 2.38e-07 | 168 | 105 | 9 | int:H2AZ2 | |
| Interaction | HMGN1 interactions | 2.38e-07 | 168 | 105 | 9 | int:HMGN1 | |
| Interaction | LARP7 interactions | H2BC11 GNL3L LARP1 LARP1B PRPF8 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MRPS17 MEPCE H2BC5 H2BC3 RPL13A EP300 H2BC12 | 2.40e-07 | 1113 | 105 | 21 | int:LARP7 |
| Interaction | ADAMTS12 interactions | 4.08e-07 | 55 | 105 | 6 | int:ADAMTS12 | |
| Interaction | EPRS1 interactions | MYO6 ERO1A HUNK PRPF8 H2BC1 H2BC13 H2BC9 H2BC4 H2BC21 MEPCE H2BC5 H2BC3 RPL13A H2BC12 | 4.43e-07 | 513 | 105 | 14 | int:EPRS1 |
| Interaction | PINK1 interactions | H2BC11 MAGED1 MYO6 LARP1 PRPF8 H2BC18 H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.45e-07 | 679 | 105 | 16 | int:PINK1 |
| Interaction | TTN interactions | NEB H2BC18 H2BC13 H2BC9 H2BC4 H2BC17 H2BC21 MEPCE H2BC5 RPL13A H2BC12 | 4.61e-07 | 299 | 105 | 11 | int:TTN |
| Interaction | CD81 interactions | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC5 H2BC3 H2BC12 | 5.26e-07 | 303 | 105 | 11 | int:CD81 |
| Interaction | YY1 interactions | GTF3C3 H2BC18 H2BC13 H2BC14 H2BC9 H2BC4 MRPS17 NFRKB MEPCE H2BC5 ELK3 EP300 H2BC12 | 6.89e-07 | 454 | 105 | 13 | int:YY1 |
| Interaction | MAPK7 interactions | 8.24e-07 | 143 | 105 | 8 | int:MAPK7 | |
| Interaction | H4C7 interactions | 1.00e-06 | 35 | 105 | 5 | int:H4C7 | |
| Interaction | PPM1G interactions | H2BC11 PRPF8 H2BC1 H2BC13 H2BC14 H2BC21 MEPCE H2BC5 H2BC3 EP300 H2BC12 | 1.05e-06 | 325 | 105 | 11 | int:PPM1G |
| Interaction | NAP1L4 interactions | 1.32e-06 | 206 | 105 | 9 | int:NAP1L4 | |
| Interaction | H4C9 interactions | 1.54e-06 | 108 | 105 | 7 | int:H4C9 | |
| Interaction | H2BC8 interactions | H2BC11 GNL3L NOL9 ATAD2 H2BC18 ESF1 H2BC9 H2BC17 NFRKB BUD31 MEPCE SMARCA1 SUGP1 H2BC5 | 1.74e-06 | 576 | 105 | 14 | int:H2BC8 |
| Interaction | H3-5 interactions | 2.22e-06 | 114 | 105 | 7 | int:H3-5 | |
| Interaction | TOP2A interactions | H2BC11 MYO6 PRPF8 H2BC18 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 PRKG1 EP300 H2BC12 | 3.10e-06 | 520 | 105 | 13 | int:TOP2A |
| Interaction | NPM1 interactions | LARP1 TEX15 NOL9 NEB PRPF8 ESF1 SETD2 H2BC14 H2BC4 H2BC21 MRPS17 PIK3R1 ASPM MEPCE H2BC3 H2BC20P RPL22L1 RPL13A SPTY2D1 EP300 | 3.35e-06 | 1201 | 105 | 20 | int:NPM1 |
| Interaction | TMA7 interactions | 4.03e-06 | 46 | 105 | 5 | int:TMA7 | |
| Interaction | H2AC8 interactions | 4.08e-06 | 177 | 105 | 8 | int:H2AC8 | |
| Interaction | LCK interactions | MYO1D MYO6 H2BC18 H2BC13 H2BC15 H2BC14 H2BC9 PIK3R1 H2BC5 RPL22L1 EP300 VAV1 | 5.30e-06 | 463 | 105 | 12 | int:LCK |
| Interaction | PRKCB interactions | 7.54e-06 | 255 | 105 | 9 | int:PRKCB | |
| Interaction | ZNF469 interactions | 7.55e-06 | 8 | 105 | 3 | int:ZNF469 | |
| Interaction | SNIP1 interactions | LARP1 NOL9 PRPF8 ATAD2 ESF1 H2BC9 UTP11 BUD31 MEPCE SPTY2D1 EP300 | 1.14e-05 | 417 | 105 | 11 | int:SNIP1 |
| Interaction | KNOP1 interactions | 1.26e-05 | 272 | 105 | 9 | int:KNOP1 | |
| Interaction | C11orf58 interactions | 1.47e-05 | 101 | 105 | 6 | int:C11orf58 | |
| Interaction | MACROH2A2 interactions | 1.48e-05 | 211 | 105 | 8 | int:MACROH2A2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p22 | H2BC11 H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC5 H2BC3 H2BC12 | 1.41e-09 | 378 | 106 | 11 | chr6p22 |
| Cytoband | 6p22.1 | 1.04e-06 | 142 | 106 | 6 | 6p22.1 | |
| Cytoband | 1q21.2 | 2.32e-05 | 71 | 106 | 4 | 1q21.2 | |
| Cytoband | 19q13.3 | 4.09e-05 | 82 | 106 | 4 | 19q13.3 | |
| Cytoband | 1q31 | 8.80e-04 | 19 | 106 | 2 | 1q31 | |
| Cytoband | 7q22.1 | 2.33e-03 | 113 | 106 | 3 | 7q22.1 | |
| Cytoband | 6p21.3 | 2.76e-03 | 250 | 106 | 4 | 6p21.3 | |
| Cytoband | 8q24.13 | 3.16e-03 | 36 | 106 | 2 | 8q24.13 | |
| GeneFamily | Histones | H2BC11 H2BC18 H2BC12L H2BC1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P H2BC12 | 1.10e-20 | 116 | 73 | 16 | 864 |
| GeneFamily | ETS transcription factor family | 1.92e-04 | 28 | 73 | 3 | 534 | |
| GeneFamily | La ribonucleoprotein domain containing|RNA binding motif containing | 3.33e-04 | 7 | 73 | 2 | 625 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 1.42e-03 | 14 | 73 | 2 | 1095 | |
| GeneFamily | V-type ATPases | 3.85e-03 | 23 | 73 | 2 | 415 | |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | 4.19e-03 | 24 | 73 | 2 | 891 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 4.54e-03 | 25 | 73 | 2 | 504 | |
| GeneFamily | Sterile alpha motif domain containing | 5.42e-03 | 88 | 73 | 3 | 760 | |
| GeneFamily | SH2 domain containing | 7.93e-03 | 101 | 73 | 3 | 741 | |
| Coexpression | GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_DN | 1.32e-06 | 199 | 104 | 8 | M9954 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_DN | 1.38e-06 | 200 | 104 | 8 | M9952 | |
| Coexpression | HASLINGER_B_CLL_WITH_6Q21_DELETION | 1.62e-06 | 22 | 104 | 4 | M7362 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_UP | 5.45e-06 | 111 | 104 | 6 | MM705 | |
| Coexpression | NUYTTEN_NIPP1_TARGETS_UP | H2BC11 PCTP H2BC12L H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 MMP7 H2BC12 | 1.12e-05 | 768 | 104 | 13 | M6444 |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_14_PRECICTIVE_ICB_RESPONSE | 1.44e-05 | 198 | 104 | 7 | MM17083 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | MAGED1 BZW2 ATAD2 LANCL2 SLC8A1 H2BC13 H2BC15 ALMS1 DBF4 ASPM SMARCA1 H2BC3 | 1.65e-05 | 680 | 104 | 12 | MM456 |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_UP | 4.10e-05 | 96 | 104 | 5 | M1683 | |
| Coexpression | FIRESTEIN_PROLIFERATION | 5.36e-05 | 166 | 104 | 6 | M5354 | |
| Coexpression | XU_GH1_EXOGENOUS_TARGETS_DN | 6.29e-05 | 105 | 104 | 5 | M17387 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_CYCLING_DEFINITIVE_ERYTHROBLAST | 7.79e-05 | 450 | 104 | 9 | M45747 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | H2BC11 ATAD2 H2BC18 ANKRD36B H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 ALMS1 DBF4 ASPM H2BC3 | 8.87e-05 | 939 | 104 | 13 | M45768 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | H2BC11 ATAD2 H2BC18 H2BC13 H2BC15 H2BC9 H2BC4 PPP5C DBF4 ASPM H2BC3 | 9.92e-05 | 694 | 104 | 11 | M45767 |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | H2BC11 BZW2 PRPF8 MADD H2BC18 H2BC13 DENND6A H2BC4 H2BC17 PPP5C DBF4 H2BC5 ELK4 SPTY2D1 H2BC12 | 1.11e-04 | 1239 | 104 | 15 | M1743 |
| Coexpression | GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_UP | 1.20e-04 | 192 | 104 | 6 | M4174 | |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | H2BC11 H2BC18 H2BC13 H2BC9 H2BC4 H2BC17 ALMS1 ASPM H2BC5 H2BC3 H2BC12 | 1.27e-04 | 714 | 104 | 11 | M1744 |
| Coexpression | GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_DN | 1.45e-04 | 199 | 104 | 6 | M7667 | |
| Coexpression | GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP | 1.45e-04 | 199 | 104 | 6 | M3474 | |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_THYMUS_UP | 1.45e-04 | 199 | 104 | 6 | M1746 | |
| Coexpression | GSE411_UNSTIM_VS_400MIN_IL6_STIM_MACROPHAGE_UP | 1.49e-04 | 200 | 104 | 6 | M5999 | |
| Coexpression | GSE18893_CTRL_VS_TNF_TREATED_TREG_24H_DN | 1.49e-04 | 200 | 104 | 6 | M7296 | |
| Coexpression | GSE3982_MAST_CELL_VS_BCELL_UP | 1.49e-04 | 200 | 104 | 6 | M5434 | |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_THYMUS_UP | 1.49e-04 | 200 | 104 | 6 | MM1033 | |
| Coexpression | VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_9MO_UP | 1.55e-04 | 127 | 104 | 5 | M40952 | |
| Coexpression | GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_UP | 1.79e-04 | 131 | 104 | 5 | M8922 | |
| CoexpressionAtlas | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K3 | 8.67e-09 | 32 | 102 | 6 | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MandArch_2500_K1 | H2BC11 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC17 H2BC5 H2BC12 | 9.17e-09 | 125 | 102 | 9 | facebase_RNAseq_e9.5_MandArch_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K4 | 4.48e-08 | 70 | 102 | 7 | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K4 | |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_bud_2500_K2 | 1.42e-07 | 50 | 102 | 6 | gudmap_RNAseq_e11.5_Ureteric_bud_2500_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K0 | 1.02e-06 | 110 | 102 | 7 | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K0 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K1 | 1.28e-06 | 72 | 102 | 6 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_FaceMes_2500 | H2BC11 BZW2 NOL9 EYA1 H2BC18 DOCK5 H2BC1 H2BC13 H2BC15 H2BC14 H2BC17 PPP5C CCDC42 DBF4 H2BC5 H2BC3 RPL22L1 H2BC12 SLC27A2 | 5.24e-06 | 1226 | 102 | 19 | facebase_RNAseq_e9.5_FaceMes_2500 |
| CoexpressionAtlas | facebase_RNAseq_e9.5_FaceMes_2500_K2 | 6.08e-06 | 54 | 102 | 5 | facebase_RNAseq_e9.5_FaceMes_2500_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K4 | 8.67e-06 | 58 | 102 | 5 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K2 | 1.08e-05 | 157 | 102 | 7 | facebase_RNAseq_e8.5_FloorPlate_2500_K2 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Mesangium_2500_K4 | 1.33e-05 | 162 | 102 | 7 | gudmap_RNAseq_e15.5_Mesangium_2500_K4 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3 | 2.15e-05 | 397 | 102 | 10 | GSM791143_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_OlfacPit_2500_K1 | H2BC11 HUNK H2BC1 H2BC13 H2BC15 H2BC14 H2BC17 H2BC5 H2BC12 SLC27A2 | 2.39e-05 | 402 | 102 | 10 | facebase_RNAseq_e10.5_OlfacPit_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MaxArch_2500_K4 | H2BC11 BZW2 NOL9 EYA1 H2BC18 DOCK5 H2BC1 H2BC13 H2BC15 H2BC14 H2BC17 DBF4 DYRK1B H2BC5 H2BC3 H2BC12 SLC27A2 | 2.43e-05 | 1125 | 102 | 17 | facebase_RNAseq_e9.5_MaxArch_2500_K4 |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | 2.77e-05 | 409 | 102 | 10 | GSM399452_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.35e-05 | 187 | 102 | 7 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#1 | 4.19e-05 | 80 | 102 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_ParaxMesoderm_2500 | H2BC11 BZW2 ERO1A LMBR1 NOL9 EYA1 H2BC18 DOCK5 H2BC1 H2BC13 H2BC15 H2BC14 H2BC17 PPP5C DBF4 H2BC5 H2BC3 RPL22L1 H2BC12 | 4.46e-05 | 1429 | 102 | 19 | facebase_RNAseq_e8.5_ParaxMesoderm_2500 |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Podocytes_2500_K1 | 5.36e-05 | 43 | 102 | 4 | gudmap_RNAseq_e15.5_Podocytes_2500_K1 | |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K1 | 1.14e-04 | 52 | 102 | 4 | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K1 | |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | 1.29e-04 | 398 | 102 | 9 | GSM399397_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | THNSL1 TEX15 LARP1B ATAD2 MADD ESF1 H2BC1 ALMS1 PPP5C DBF4 SUGP1 RPL13A SLC27A2 | 1.51e-04 | 820 | 102 | 13 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 1.61e-04 | 410 | 102 | 9 | GSM538387_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_OlfacPit_2500 | H2BC11 LMBR1 EYA1 HUNK ELL3 H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC17 ALMS1 DBF4 DYRK1B H2BC5 H2BC3 H2BC12 SLC27A2 | 1.78e-04 | 1453 | 102 | 18 | facebase_RNAseq_e10.5_OlfacPit_2500 |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2 | 1.99e-04 | 422 | 102 | 9 | GSM538355_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.34e-04 | 115 | 102 | 5 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_FaceMes_2500_K4 | BZW2 NOL9 EYA1 H2BC18 DOCK5 H2BC1 H2BC13 H2BC15 H2BC17 PPP5C DBF4 H2BC3 RPL22L1 SLC27A2 | 2.53e-04 | 983 | 102 | 14 | facebase_RNAseq_e9.5_FaceMes_2500_K4 |
| CoexpressionAtlas | alpha beta T cells, NKT.4+.Sp, TCRb aGalCer-loaded CD1d tetramer CD4, Spleen, avg-1 | 2.71e-04 | 347 | 102 | 8 | GSM538322_500 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MaxArch_2500 | H2BC11 BZW2 NOL9 EYA1 H2BC18 DOCK5 H2BC1 H2BC13 H2BC15 H2BC14 H2BC17 DBF4 DYRK1B H2BC5 H2BC3 H2BC12 SLC27A2 | 2.73e-04 | 1371 | 102 | 17 | facebase_RNAseq_e9.5_MaxArch_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.93e-04 | 265 | 102 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#3 | 3.14e-04 | 268 | 102 | 7 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K3 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_500 | 3.23e-04 | 68 | 102 | 4 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 3.40e-04 | 359 | 102 | 8 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K3 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | MYO6 LARP1 EYA1 HUNK H2BC13 H2BC9 ALMS1 ASPM H2BC3 CAMTA1 EPHA4 EPHA7 | 3.75e-04 | 783 | 102 | 12 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | 3.83e-04 | 277 | 102 | 7 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K3 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_500 | 3.98e-04 | 129 | 102 | 5 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k4_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_500_k-means-cluster#1 | 4.42e-04 | 132 | 102 | 5 | Facebase_RNAseq_e9.5_Facial Mesenchyne_500_K1 | |
| CoexpressionAtlas | B cells, B.GC.Sp, CD19+ IgM+ IgD- GL7+ PNA+, Spleen, avg-3 | 4.96e-04 | 380 | 102 | 8 | GSM538207_500 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_OlfPlac_2500_K3 | LMBR1 GRB14 NOL9 EYA1 HUNK H2BC18 H2BC1 H2BC13 H2BC15 H2BC14 H2BC17 PPP5C DBF4 DYRK1B H2BC3 | 5.34e-04 | 1187 | 102 | 15 | facebase_RNAseq_e9.5_OlfPlac_2500_K3 |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2 | 5.69e-04 | 388 | 102 | 8 | GSM538352_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | THNSL1 TEX15 NOL9 LARP1B ATAD2 GTF3C3 H2BC1 ALMS1 PPP5C DBF4 RPL13A SLC27A2 | 5.78e-04 | 822 | 102 | 12 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d6.LisOva, CD8+ CD45.1+, Spleen, avg-3 | 7.17e-04 | 402 | 102 | 8 | GSM605898_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#3_top-relative-expression-ranked_500 | 7.22e-04 | 147 | 102 | 5 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k3_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000 | SHANK1 H2BC11 MYO1D H2BC18 H2BC1 SLC8A1 H2BC15 H2BC14 H2BC4 H2BC21 H2BC3 SLC27A2 EPHA4 | 7.39e-04 | 968 | 102 | 13 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000 |
| CoexpressionAtlas | B cells, MLP.BM, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Bone marrow, avg-2 | 7.40e-04 | 404 | 102 | 8 | GSM791129_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#2 | 7.44e-04 | 148 | 102 | 5 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K2 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_100 | 7.54e-04 | 85 | 102 | 4 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_100 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_500 | 7.64e-04 | 406 | 102 | 8 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#5 | 7.64e-04 | 406 | 102 | 8 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#2 | 7.90e-04 | 313 | 102 | 7 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#4 | 8.20e-04 | 315 | 102 | 7 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K4 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.e17.Th, TCRd+ Vg2+ CD24+, Fetal Thymus, avg-3 | 8.67e-04 | 414 | 102 | 8 | GSM476660_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | FAM91A1 H2BC18 H2BC1 H2BC13 H2BC14 H2BC9 DYRK1B MEPCE SUGP1 H2BC3 | 8.94e-04 | 629 | 102 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K1 |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | 9.09e-04 | 417 | 102 | 8 | GSM399403_500 | |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Fetal Liver, avg-1 | 9.23e-04 | 418 | 102 | 8 | GSM538350_500 | |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2 | 9.37e-04 | 419 | 102 | 8 | GSM538348_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg3+24alo.e17.Th, TCRd+ Vg3+ CD24-, Fetal Thymus, avg-3 | 9.37e-04 | 419 | 102 | 8 | GSM476664_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#1 | 9.80e-04 | 236 | 102 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K1 | |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1 | 9.81e-04 | 422 | 102 | 8 | GSM538357_500 | |
| CoexpressionAtlas | Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3 | 9.96e-04 | 423 | 102 | 8 | GSM791126_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6+.Th.TCRbko, TCRd+ Vg1.1+ Vd6.3+, Thymus, avg-3 | 1.02e-03 | 327 | 102 | 7 | GSM605778_500 | |
| CoexpressionAtlas | mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K3 | H2BC11 BZW2 NOL9 HUNK ELL3 H2BC1 H2BC13 H2BC15 H2BC14 H2BC17 H2BC5 H2BC3 RPL22L1 H2BC12 SLC27A2 | 1.03e-03 | 1266 | 102 | 15 | mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K3 |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_tips_2500_K4 | 1.12e-03 | 431 | 102 | 8 | gudmap_RNAseq_e11.5_Ureteric_tips_2500_K4 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | MAGED1 BZW2 GRB14 EYA1 HUNK ATAD2 H2BC13 ASPM SMARCA1 H2BC3 EPHA7 | 1.15e-03 | 768 | 102 | 11 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | B cells, B.Pl.AA4+220+.BM, CD138+ AA4.1+ CD43- CD45R+, Bone marrow, avg-3 | 1.21e-03 | 337 | 102 | 7 | GSM777024_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#5_top-relative-expression-ranked_200 | 1.22e-03 | 11 | 102 | 2 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_200_k5 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.23e-03 | 97 | 102 | 4 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k2_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_200 | 1.32e-03 | 45 | 102 | 3 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k1_200 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K2 | BZW2 ERO1A LMBR1 NOL9 EYA1 H2BC18 DOCK5 H2BC1 H2BC13 H2BC15 PPP5C DBF4 H2BC3 RPL22L1 | 1.46e-03 | 1175 | 102 | 14 | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K2 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | THNSL1 ERO1A TEX15 NOL9 ATAD2 GTF3C3 ESF1 ALMS1 DBF4 RPL13A SLC27A2 | 1.52e-03 | 795 | 102 | 11 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#5 | 1.60e-03 | 104 | 102 | 4 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K5 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.21e-08 | 180 | 106 | 8 | 1be264962fd4ed0bb59f9b8a6956c4239ca32e05 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.21e-08 | 180 | 106 | 8 | 5568063c2518fadb638e665635061ec10d00fb6a | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.35e-08 | 196 | 106 | 8 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK-Cycling_NK|Lung / Manually curated celltypes from each tissue | 1.95e-07 | 173 | 106 | 7 | d815832f89f70662706620e3b03ebb1dabec0034 | |
| ToppCell | Lymphoid-Lymphoid-T_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 2.64e-07 | 181 | 106 | 7 | b6b41cd5d43543fe7a093033dae52a789199db0e | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-07 | 186 | 106 | 7 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-07 | 186 | 106 | 7 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | mild_COVID-19_(asymptomatic)-Platelet|World / disease group, cell group and cell class (v2) | 3.67e-07 | 190 | 106 | 7 | 7aaf82f0c235363afb95cf1fa51c2a5b070b1af8 | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 4.08e-07 | 193 | 106 | 7 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.69e-07 | 197 | 106 | 7 | fd76cc5e12c7e7943a48f739e4f0626ff7211f51 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.19e-07 | 200 | 106 | 7 | 7f5cd05bb1b9a83baceddb7d7f0a9ec9781cda29 | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Epithelial-Lgr5+_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 139 | 106 | 6 | c300f953ff9c5e820ff16bcd9942d279b37b79db | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 139 | 106 | 6 | 95b19d7459d9b54162cf01d278462245d34802d5 | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte1_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.18e-06 | 158 | 106 | 6 | 944c5fe625f965dd6153dbcbf5577f99ad343983 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.10e-06 | 168 | 106 | 6 | 2d056cfbb470a088a0682576753535fb4528d48f | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.10e-06 | 168 | 106 | 6 | 2f69e248c6fab1421c0081e01e1920e6ffcde344 | |
| ToppCell | facs-SCAT-Fat-18m-Lymphocytic-T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-06 | 169 | 106 | 6 | 700a3a36c379872585204caa6a6cc269b036ae22 | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.32e-06 | 170 | 106 | 6 | 5319f73cff64f2bb67472c7156ee1d0f006c6fc0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.44e-06 | 171 | 106 | 6 | 39c8ae139e449217091e1481eb5e2aafb8f69a1c | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.80e-06 | 174 | 106 | 6 | 021ebc6ec022b992d7b25333ba0b7416371e041b | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.80e-06 | 174 | 106 | 6 | 65147b0f8c2ccadd5685430d31081520c157536a | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.80e-06 | 174 | 106 | 6 | c2fc78dd6c440737ded59676961e4c7b923084ce | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.19e-06 | 177 | 106 | 6 | a4c001a8e44142babf9f24dfe6f7b73a70b11b16 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.19e-06 | 177 | 106 | 6 | 363e07b0f347f3716d530a28ead854b98e27d37c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.33e-06 | 178 | 106 | 6 | c20f050344a2e120e685e2a7fe36c6dfc1dc37b6 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.47e-06 | 179 | 106 | 6 | b88791dd4e73bb8410ca090938a1a45b0bc16e69 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B_plasma-Plasmablasts|Lung / Manually curated celltypes from each tissue | 4.47e-06 | 179 | 106 | 6 | 3fa75eec3e86fd1797eaa33362257df7f9b2a0bf | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.47e-06 | 179 | 106 | 6 | c063028b82c68d929aef2421daade9dc189a6963 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mast-Mast-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.77e-06 | 181 | 106 | 6 | c35ca98c474e31917e0a53c092397e0d8d18b37c | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-06 | 181 | 106 | 6 | 9fce5eee75684a7ecac6996e26e9215bc95098b2 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-06 | 181 | 106 | 6 | ad97e802e934738ddece675232a72308db2da256 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.92e-06 | 182 | 106 | 6 | 0370b395ceb9d4d66f80cf60dd8c28ac60af5c7b | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.92e-06 | 182 | 106 | 6 | 39f9b3eb22293cc27c6e175702c77d1eeb24fdc9 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B_plasma-Plasma_cells|GI_large-bowel / Manually curated celltypes from each tissue | 5.41e-06 | 185 | 106 | 6 | 2cad994207c4afc9d70f4c2d243ffbbcdbba693e | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B_plasma|GI_large-bowel / Manually curated celltypes from each tissue | 5.41e-06 | 185 | 106 | 6 | 989583c487d8c121e3731faf68f863ba43a582e6 | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.41e-06 | 185 | 106 | 6 | 698ff44fd2d9b3ad5cea45f4cff9bfc64c559b62 | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.57e-06 | 186 | 106 | 6 | 981116561986f94e9cc3ee64fb37dab9a31d427a | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-06 | 189 | 106 | 6 | bfa3ed1360991a3e32fad133017c413f8adc1eba | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-06 | 189 | 106 | 6 | 96f10c63656e446b4bb712f012e91ae986f8c2d0 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.89e-06 | 193 | 106 | 6 | 9c2f58b4c89dc084a1a6e53952ea793e87a96660 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.89e-06 | 193 | 106 | 6 | db881cc129b45031fd84d052768cef53508de196 | |
| ToppCell | PCW_07-8.5|World / Celltypes from embryonic and fetal-stage human lung | 7.09e-06 | 194 | 106 | 6 | 5759c83308df017f1faae248e9b85388e25254f0 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.30e-06 | 195 | 106 | 6 | 027075e9c62b5754a014a9d1393e1b0f5ae42e41 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 7.30e-06 | 195 | 106 | 6 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-06 | 195 | 106 | 6 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-06 | 195 | 106 | 6 | 294c74336fafc1bad237d851efb4a487475078eb | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Myeloid-Megakaryocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.30e-06 | 195 | 106 | 6 | 1bcc0c8b1281396b1433ce5a2ec8681de47ce9ad | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-06 | 195 | 106 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-06 | 195 | 106 | 6 | 5749ea833be84e262e3d0a4fe1a9a373f0ef545f | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-06 | 195 | 106 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Mild_COVID-19-T/NK-proliferating_T/NK|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 7.74e-06 | 197 | 106 | 6 | 5fd52fba2cb6fa67377f873da2ff6ce9c83b0591 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.74e-06 | 197 | 106 | 6 | 434a5686a103bb766e0d80038413f0e12ea3981a | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.74e-06 | 197 | 106 | 6 | 6bddfa199ca812d9e518eaa02c3d4fb67e9f5b16 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.74e-06 | 197 | 106 | 6 | c0a71a9452febda433bc544e4ac0a79c43dcf13e | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_basal-Dividing_Basal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.74e-06 | 197 | 106 | 6 | 0a6754a5109bec0d0de42adbfdf4db43ff60c3d2 | |
| ToppCell | Caecum-B_cell-B_cell_cycling|Caecum / Region, Cell class and subclass | 7.97e-06 | 198 | 106 | 6 | 61294fe99a5641ad359796022c3d038470076b3c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.97e-06 | 198 | 106 | 6 | d484ac79d6cd29f1d9c192d126c2099f737d5320 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.97e-06 | 198 | 106 | 6 | ac0be1666456cfa8d68588b187d65008e6d5c0e2 | |
| ToppCell | Caecum-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass | 7.97e-06 | 198 | 106 | 6 | d2def132f3efe9305a5501a96ec82efb1f02c3f7 | |
| ToppCell | Caecum-(2)_B_cell-(24)_B_cell_cycling|Caecum / shred on region, Cell_type, and subtype | 7.97e-06 | 198 | 106 | 6 | 568d47770cd20c6569ca84ea1eafde367642d68b | |
| ToppCell | NS-critical-d_16-33-Lymphoid-NKT-proliferating|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.20e-06 | 199 | 106 | 6 | 31b144bb209c629e12156f4d9c9cec79baffffb9 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 8.44e-06 | 200 | 106 | 6 | 7c495030e6566b81d97b5516d1972e335ce5ed8c | |
| ToppCell | NS-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.44e-06 | 200 | 106 | 6 | d51e5c8c154b073caaf0cc09a3a3c0aafd57e44b | |
| ToppCell | Sigmoid-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | 8.44e-06 | 200 | 106 | 6 | 4e489ecf472857357d45e9f6c7a812aa48b72ebf | |
| ToppCell | PSB-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.44e-06 | 200 | 106 | 6 | 3e3de496508efb2f95e5e8684f97687381e96493 | |
| ToppCell | BL-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.44e-06 | 200 | 106 | 6 | 04d95a9102248e98eed069840ea6d3d23a243fd5 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.70e-05 | 147 | 106 | 5 | 22d71cf92b957e5a8aa63b13157626d013d6752b | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.98e-05 | 150 | 106 | 5 | 744050a1b665c6989f37141348af3df7579a73c9 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-05 | 154 | 106 | 5 | 66c93733116e31b65dfb4b0b00de5c39d19cdb84 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.82e-05 | 158 | 106 | 5 | c736834269c89e003c61a62b63e4e50dbf0e1538 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.05e-05 | 160 | 106 | 5 | 5cc1b75e3c20d83112b3aa2f3c749a6c73910a2d | |
| ToppCell | Control-Lymphocyte-B-Plasmablast|Control / Disease, Lineage and Cell Type | 4.30e-05 | 162 | 106 | 5 | 67b32c40cc180c5ebbfd901a417b5be469500110 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.69e-05 | 165 | 106 | 5 | 26c750f10f6401752e2e63d91dc844c81b29d735 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.11e-05 | 168 | 106 | 5 | a7eb28e15b591997f1aee09501cb20ae18beca08 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.26e-05 | 169 | 106 | 5 | 20fbf78382fb0ba9a63ab1aa0abc615476994ac5 | |
| ToppCell | droplet-Lung-30m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.26e-05 | 169 | 106 | 5 | 822e5b6c1e55e196e6d2a38bf183fd220c45703e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.41e-05 | 170 | 106 | 5 | cf22a843ae2d9cd6693507fed2b7c6a45abea10e | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.56e-05 | 171 | 106 | 5 | 48125d825ca2d7ef34564250f5b47d2a579e03c9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 171 | 106 | 5 | c2dbc439af28d4fabb24d57685b75b2e588819b0 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B_plasma|Lung / Manually curated celltypes from each tissue | 5.71e-05 | 172 | 106 | 5 | 8156fb6de66a4c92ade703b71c2e9187291e50ef | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.87e-05 | 173 | 106 | 5 | a5172dee859bf6c2eed46c48bd64dfef0ff9f28f | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.87e-05 | 173 | 106 | 5 | 639b5b0b33ce5aa0bc26363c059717012ddc14c0 | |
| ToppCell | droplet-Lung-1m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.87e-05 | 173 | 106 | 5 | c399786aa25bdbe3394988db6955842b5b7e6b41 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.87e-05 | 173 | 106 | 5 | 31784679190fbd95fc23d7c66008eb21b8c7cc5d | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-Cycling_Dendritic|Lung / Manually curated celltypes from each tissue | 5.87e-05 | 173 | 106 | 5 | 62e0c18cfed9645e34a9d7029c94a8554f773714 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.04e-05 | 174 | 106 | 5 | b31a6c9d8f7c8cb229c0539d959c19251e2fcd13 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.20e-05 | 175 | 106 | 5 | 9de288c338cee67be0e9b836c87799bbc1db1c38 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.20e-05 | 175 | 106 | 5 | 74800a10f5ff25d5414fbccb0668f92ff077d1cc | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.55e-05 | 177 | 106 | 5 | 26c25d10aa511b64cc7db43a8deea7b5d31bca96 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.72e-05 | 178 | 106 | 5 | 2c581a338bf33dbd2be9abe87d0a84f97dfb546f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.72e-05 | 178 | 106 | 5 | 5caeffb70cbb868586bd260b44ccd3751bbfa615 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Hematopoietic-Megakaryocytic|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.72e-05 | 178 | 106 | 5 | afc3220e2319cb38d59307db1b793a3915e1d5c4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Hematopoietic|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.72e-05 | 178 | 106 | 5 | 4ff23a0bb20c4373db14bfaad18b5fa5c7c78e76 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.27e-05 | 181 | 106 | 5 | e4dbc09f0210de465d8347969b301c22463a2b7d | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-05 | 182 | 106 | 5 | 9025178ede571e3808d4657ad4892152f336c9b4 | |
| ToppCell | COVID-19_Mild|World / Disease Group and Platelet Clusters | 7.47e-05 | 182 | 106 | 5 | 90c61e10c7860bfba6ccfe6f37671c8924637f7b | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-05 | 182 | 106 | 5 | c075756cd4bb484ede1be2bcdb9eac60eab0573a | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.66e-05 | 183 | 106 | 5 | 769a022fe8568ec49e66f792cc5777e713a7571c | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.66e-05 | 183 | 106 | 5 | aac0695fafa59cabd920ee18b1139d3e00d898e8 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi-Sox9_Epi_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.86e-05 | 184 | 106 | 5 | e93633d89a9c54c8d2819f56372815b4ca149f06 | |
| Computational | Genes in the cancer module 89. | 1.03e-06 | 14 | 63 | 4 | MODULE_89 | |
| Computational | Genes in the cancer module 203. | 1.85e-06 | 16 | 63 | 4 | MODULE_203 | |
| Computational | Genes in the cancer module 90. | 2.41e-06 | 17 | 63 | 4 | MODULE_90 | |
| Computational | Chromatin and nucleosomes. | 3.08e-06 | 18 | 63 | 4 | MODULE_552 | |
| Computational | Genes in the cancer module 534. | 3.08e-06 | 18 | 63 | 4 | MODULE_534 | |
| Computational | Genes in the cancer module 222. | 7.24e-06 | 22 | 63 | 4 | MODULE_222 | |
| Computational | Genes in the cancer module 168. | 7.24e-06 | 22 | 63 | 4 | MODULE_168 | |
| Computational | Genes in the cancer module 189. | 8.73e-06 | 23 | 63 | 4 | MODULE_189 | |
| Computational | Genes in the cancer module 127. | 1.45e-05 | 26 | 63 | 4 | MODULE_127 | |
| Computational | Chromatin. | 1.97e-05 | 28 | 63 | 4 | MODULE_421 | |
| Drug | Methylmethacrylate | 1.26e-13 | 39 | 105 | 9 | ctd:D020366 | |
| Drug | Berberine | H2BC11 SETD2 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC5 EP300 H2BC12 | 2.46e-09 | 202 | 105 | 11 | ctd:D001599 |
| Disease | Inguinal hernia | 6.24e-06 | 287 | 100 | 8 | HP_0000023 | |
| Disease | reticulocyte count | MYO1D BZW2 NAB1 LARP1 GRB14 NOL9 EYA1 PRPF8 NLRP6 DOCK5 H2BC4 PIK3R1 NFRKB | 5.26e-05 | 1045 | 100 | 13 | EFO_0007986 |
| Disease | cholesteryl ester measurement | 2.48e-04 | 257 | 100 | 6 | EFO_0010351 | |
| Disease | 2-aminooctanoate measurement | 3.14e-04 | 8 | 100 | 2 | EFO_0800349 | |
| Disease | Adenocarcinoma of lung (disorder) | 6.95e-04 | 206 | 100 | 5 | C0152013 | |
| Disease | N-delta-acetylornithine measurement | 7.34e-04 | 12 | 100 | 2 | EFO_0800067 | |
| Disease | Metastatic melanoma | 8.26e-04 | 54 | 100 | 3 | C0278883 | |
| Disease | reticulocyte measurement | MYO1D BZW2 NAB1 LARP1 GRB14 NOL9 EYA1 PRPF8 DOCK5 H2BC4 PIK3R1 | 8.87e-04 | 1053 | 100 | 11 | EFO_0010700 |
| Disease | hypertension (biomarker_via_orthology) | 1.07e-03 | 227 | 100 | 5 | DOID:10763 (biomarker_via_orthology) | |
| Disease | N-acetylmethionine measurement | 1.16e-03 | 15 | 100 | 2 | EFO_0021427 | |
| Disease | N-acetylarginine measurement | 1.32e-03 | 16 | 100 | 2 | EFO_0021429 | |
| Disease | rosacea severity measurement | 1.60e-03 | 147 | 100 | 4 | EFO_0009180 | |
| Disease | Alzheimer's disease (is_marker_for) | 1.85e-03 | 257 | 100 | 5 | DOID:10652 (is_marker_for) | |
| Disease | hemoglobin A1 measurement | 1.98e-03 | 520 | 100 | 7 | EFO_0007629 | |
| Disease | smoking status measurement, systolic blood pressure | 1.99e-03 | 156 | 100 | 4 | EFO_0006335, EFO_0006527 | |
| Disease | Mammary Carcinoma, Human | 2.09e-03 | 525 | 100 | 7 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.09e-03 | 525 | 100 | 7 | C1257931 | |
| Disease | Mammary Neoplasms | 2.14e-03 | 527 | 100 | 7 | C1458155 | |
| Disease | amino acid measurement | 2.17e-03 | 678 | 100 | 8 | EFO_0005134 | |
| Disease | Breast Carcinoma | 2.40e-03 | 538 | 100 | 7 | C0678222 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RFTKKEIKNIRAFYY | 266 | Q6UWY0 | |
| KKVSARRYNEDYLKY | 56 | P0CF97 | |
| VYRREAVKSYKSYDF | 76 | O60825 | |
| YNRKTSRVYKYCSKL | 1131 | Q09472 | |
| YAQVFNKLIRRYKYL | 111 | Q9Y6E2 | |
| KTRYIFDLFYKRKAI | 56 | P41223 | |
| AAVLIQKYYRSYKKC | 1596 | Q9Y6Y1 | |
| YKKFRKQYPSYREEK | 356 | Q9HB65 | |
| YFRKEDREKYFKKFF | 206 | Q13939 | |
| IKKLQERDYFRYYKV | 61 | Q86YB8 | |
| EYKSYRLRAQLYKKR | 4141 | Q8TCU4 | |
| LYNRKKVKYRKDGYL | 76 | O94983 | |
| RVIFDLIYEYKRKRY | 231 | Q8N2N9 | |
| QKRYYLRQRKATVYY | 291 | Q6PL18 | |
| RLSAKLKDYYIFNKY | 141 | Q96M95 | |
| LIREYLEFNKYKYTA | 56 | Q96NB1 | |
| RYYIEQKKKELYLLK | 176 | Q9UBU7 | |
| YKHINEVYYAKKKRR | 56 | Q9Y463 | |
| KRSRKESYSVYVYKV | 31 | P57053 | |
| YSTRQRFLKLKYYSI | 1361 | Q8IZT6 | |
| KIQSYYRAYVSKKEF | 1661 | Q8IZT6 | |
| YYRLYVRVKTERKNF | 2721 | Q8IZT6 | |
| YILVYRKTNIQYDKR | 166 | Q9BYT9 | |
| DYKYLTLKVKASYRK | 111 | Q9BQ51 | |
| KRSRKESYSIYVYKV | 31 | Q16778 | |
| KRSRKESYSVYVYKV | 31 | Q5QNW6 | |
| KRSRKESYSIYVYKV | 31 | P06899 | |
| KRSRKESYSVYVYKV | 31 | Q99877 | |
| YAYYKKQRTKTDVYI | 66 | Q9NPB9 | |
| EYKDFKLIYRQYAAL | 51 | Q9Y587 | |
| YIDIVKYVFSAYKRE | 386 | Q5SY16 | |
| ELLKDYIKRQIEYYF | 401 | Q6PKG0 | |
| RYYSYGLEKKFRLDI | 956 | Q6PKG0 | |
| QDYLKRFYLYDSETK | 36 | P09237 | |
| QLNKFYTKKCRELYY | 1506 | Q8WXG6 | |
| LLTYEFVKQKYLDYR | 606 | Q9Y5V3 | |
| VKYRQLCFKSQYKRY | 121 | Q6P4R8 | |
| KRSRKESYSVYVYKV | 31 | Q99879 | |
| KRSRKESYSIYVYKV | 31 | Q6DN03 | |
| KRSRKESYSIYVYKV | 31 | Q6DRA6 | |
| RKTLTETIYKNYYRI | 626 | Q7L2J0 | |
| REVTYKYTYRTTKSK | 306 | Q13506 | |
| IVRLYRTFKDSKYLY | 421 | Q13976 | |
| LYVVSYFIITRYKRK | 31 | Q8WVP7 | |
| VQCRYEEKYKTFNKY | 41 | A0A0K2S4Q6 | |
| VKKDERRYYEELLKY | 56 | Q658Y4 | |
| YRLTQDKKYLYRACK | 381 | Q9NS86 | |
| VKYYEKDQNERSYRI | 476 | P54764 | |
| KRSRKESYSVYVYKV | 31 | P58876 | |
| KRSRKESYSVYVYKV | 31 | Q93079 | |
| KRSRKESYSVYVYKV | 31 | O60814 | |
| EKLRDYQFKRLKYYY | 421 | Q9H501 | |
| YFRRITLYLTEKKYS | 146 | P01562 | |
| DKSQTNYRIRYYKIY | 91 | Q5JST6 | |
| AYFYSRFNRIKKINK | 146 | Q99645 | |
| NYRLKEYEKALKYVR | 81 | Q9Y3D6 | |
| YDRRQKLIYFFKESL | 456 | Q8N119 | |
| FRYRRVKEIYNTYKN | 436 | Q99502 | |
| YRKYRKLIESELSYF | 421 | Q8N4B4 | |
| YQRFTIDKYLKRYEK | 931 | O95163 | |
| YQYRALYDYKKEREE | 6 | P27986 | |
| YEIKYYEKDQRERTY | 476 | Q15375 | |
| QKYAYKERRAKLYVC | 201 | O14753 | |
| VFYVVIAKKVYDSYR | 226 | Q9BPV8 | |
| IYRLLDKKTGLYEYK | 41 | Q9UKL6 | |
| RKRTRKESYSIYIYK | 31 | Q96A08 | |
| KRSRKESYSIYVYKV | 31 | P33778 | |
| KRSRKESYSVYVYKV | 31 | P62807 | |
| YFQGIRVYLKEKKYS | 146 | P05000 | |
| KRGRKESYSIYVYKV | 31 | Q8N257 | |
| YKEKKREDIYIRYLY | 1231 | Q9H7D0 | |
| RALRYYYVKNIIKKV | 61 | P28324 | |
| KRSRKESYSVYVYKV | 31 | Q99880 | |
| KRSRKESYSIYVYKV | 31 | P23527 | |
| YKTRLYQIEKYRAPK | 401 | P57058 | |
| YGYVYFRQVRDKTLK | 151 | Q8IWF6 | |
| RALRYYYDKNIIKKV | 61 | P41970 | |
| QKLLESDYFRYYKVN | 66 | Q96HE7 | |
| KAYLIDKVRIKGYYA | 916 | Q86Z14 | |
| EENKLYFRKNYAKYE | 181 | Q14449 | |
| QIYELEKRFLYQKYL | 136 | P52954 | |
| KYFYKYFRDERRAER | 356 | P59044 | |
| KEYIKRQIEYYFSVE | 216 | Q659C4 | |
| DYKLRADDYRKKQEY | 36 | Q9Y3A2 | |
| EKEILYYRKTIGYKV | 801 | P28370 | |
| YLQKKIITYDLIKYD | 386 | O14975 | |
| TRAIELDKKYIKGYY | 86 | P53041 | |
| RKAYYKEFRKVVEYS | 121 | Q9NVN8 | |
| DPYLLKYFNKRKTYF | 36 | Q9Y2R5 | |
| DRKKYKDESDYALRY | 626 | Q68D10 | |
| YLEFRYKTRVYKQTN | 151 | Q9Y566 | |
| YSFYDDRQKRKELEY | 656 | Q9Y5Q9 | |
| KNSREFLYYRKKVAE | 226 | Q8IWZ8 | |
| YKYYRQKLEEFRKAK | 306 | Q8IWZ8 | |
| VKVRVSYQKLLKYYV | 441 | Q6P2Q9 | |
| QFSKRYLKYLTKKYL | 71 | Q6P5R6 | |
| NFYRNKLKYLAFLRK | 46 | P40429 | |
| NYDKLSRSIRQYYKK | 301 | O95238 | |
| LKRYTKEYTEYNEEK | 111 | O95630 | |
| LYQVFIKYKERFLVY | 266 | P15498 | |
| LKFRRQYYKKWYDAR | 186 | Q8IYQ7 | |
| SYYFTRRKYLLKALF | 521 | Q8IYM2 | |
| KYFSYSKLERDTRYV | 376 | Q9BYW2 | |
| EKNSYYVFLKYKRQV | 1776 | Q9BXT5 | |
| LRNKLYKSYLEAFYK | 181 | Q8N8Y2 | |
| IRNTLYKAYLESFYK | 181 | P61421 | |
| IKYFFQKVILRRYDK | 91 | Q9Y2Q1 | |
| VADRRLLFYKYVYKR | 251 | P32418 | |
| TIIRYYRRYKVKSYI | 726 | O94832 | |
| ADKRLLFYKYVYKRY | 246 | Q9UPR5 | |
| NIKVRYSKDRIYTYV | 76 | Q9UM54 | |
| REYKKDFEKYKTRYS | 3316 | P20929 |